ArticleFrontiers in pediatrics2023

Aberrant myelomonocytic CD56 expression predicts response to cyclosporine therapy in pediatric patients with moderate aplastic anemia.

Shanshan Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.